SCHEMBL26065394

SCHEMBL26065394

Cc1nc(C(C)(C)F)ccc1SN1CC2(CNC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26065255 0.92 — —
SCHEMBL26065735 0.91 HTR2A (0.33) —
SCHEMBL26065392 0.78 CYP11B2 (0.37) —
SCHEMBL26065355 0.78 — —
SCHEMBL26065407 0.77 LRRK2 (0.31) —
SCHEMBL26065560 0.76 PTPN11 (0.33) —
SCHEMBL26065405 0.76 — —
SCHEMBL26065939 0.75 PDCD1LG2 (0.32) —
SCHEMBL26065417 0.75 PDE10A (0.33) —
SCHEMBL25370030 0.73 TRPV4 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 — — WO disclosed
Send feedback